T and B lymphocyte subpopulations and activation/differentiation markers in patients with selective IgA deficiency

J Litzman1, M Vlková, Z Pikulová

  • 1Department of Clinical Immunology and Allergology, St Anne's University Hospital, Faculty of Medicine, Masaryk University, Brno, Czech Republic. jiri.litzman@fnusa.cz

Insights

Selective IgA deficiency (IgAD) patients show distinct T-cell abnormalities, unlike common variable immunodeficiency (CVID). IgAD patients have altered CD4+ and CD8+ T-cells, but lack the widespread B-cell defects seen in CVID.

Area of Science:

  • Immunology
  • Clinical Medicine
  • Hematology

Background:

  • Selective IgA deficiency (IgAD) and common variable immunodeficiency (CVID) are related primary immunodeficiencies with unknown causes.
  • While lymphocyte abnormalities are documented in CVID, data on IgAD patients are scarce.
  • Understanding lymphocyte profiles in IgAD is crucial for differentiating it from CVID and elucidating pathogenesis.

Purpose of the Study:

  • To investigate and compare lymphocyte subpopulations and activation markers in IgAD patients versus CVID patients and healthy controls.
  • To identify specific T-cell and B-cell abnormalities in IgAD.
  • To determine if IgAD shares the extensive lymphocyte abnormalities observed in CVID.

Main Methods:

  • Flow cytometry was used to analyze lymphocyte subsets (CD4+, CD8+, B cells) and expression of activation/differentiation markers (CD25, HLA-DR, CD45RA, CD45RO, CD27, CD28, CD29, CD57, CD38, IgM, IgD).
  • 85 IgAD patients, 47 CVID patients, and 65 healthy controls were studied.
  • Statistical analysis involved the Mann-Whitney U-test with Bonferroni correction.

Main Results:

  • IgAD patients exhibited increased relative CD8+ T-cells and decreased absolute CD4+ T-cells compared to controls, though less pronounced than in CVID.
  • Significant findings in IgAD included decreased HLA-DR and increased CD25 on CD4+ T-cells, and decreased CD29 on CD8+ T-cells.
  • No significant abnormalities were found in B-cell developmental stages in IgAD patients, contrasting with CVID.

Conclusions:

  • IgAD patients display specific T-cell subset and activation marker alterations.
  • The majority of lymphocyte subpopulation abnormalities reported in CVID are not present in IgAD.
  • These findings suggest distinct immunological profiles for IgAD and CVID, aiding in differential diagnosis and understanding disease mechanisms.

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...